Inherited thrombophilia screening in Greek women with recurrent fetal loss. 2008

A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
Department of Internal Medicine, Division of Hematology, University of Patras, Medical School, Rion, Greece.

OBJECTIVE The present study was designed to determine the prevalence of factor V Leiden (FVL), prothrombin gene G20210A (PTG) and methylenetetrahydrofolate reductase (MTHFR C677T) mutations in women from South-Western Greece with recurrent fetal loss (RFL) and negative personal thromboembolic history. METHODS 212 women with RFL and 181 women with at least two pregnancies with normal outcome and no history of pregnancy loss were investigated for the commonest thrombophilic mutations (FVL, PTG, MTHFR C677T). Comparisons between groups were performed by Pearson's chi-square test and odd ratios were calculated. RESULTS An abnormal genotype was detected in 49 women of the study group (23.1%) and in 41 women of the control group (22.6%). CONCLUSIONS Inherited thrombophilia screening is not indicated as an initial approach in Greek women with RFL and negative personal thromboembolic history.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D005260 Female Females
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000026 Abortion, Habitual Three or more consecutive spontaneous abortions. Abortion, Recurrent,Miscarriage, Recurrent,Recurrent Early Pregnancy Loss,Habitual Abortion,Habitual Abortions,Recurrent Abortion,Recurrent Abortions,Recurrent Miscarriage,Recurrent Miscarriages
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D042965 Methylenetetrahydrofolate Reductase (NADPH2) A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This enzyme was formerly classified as EC 1.1.1.171. Methylene-THF Reductase (NADPH),5,10-Methylenetetrahydrofolate Reductase (NADPH),Methylene Tetrahydrofolate Reductase,Methylenetetrahydrofolate Reductase,Methylenetetrahydrofolate Reductase (NADPH),Tetrahydrofolate Reductase, Methylene

Related Publications

A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
November 2007, Thrombosis and haemostasis,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
January 2011, Clinical and experimental obstetrics & gynecology,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
January 2011, Obstetrics and gynecology international,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
September 2000, Current opinion in hematology,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
January 2007, Akusherstvo i ginekologiia,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
August 2012, Ginekologia polska,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
December 2013, Iranian Red Crescent medical journal,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
January 2014, Clinical and experimental obstetrics & gynecology,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
October 2015, Blood cells, molecules & diseases,
A Mougiou, and G Androutsopoulos, and M Karakantza, and E Theodori, and G Decavalas, and N Zoumbos
September 2008, Ginekologia polska,
Copied contents to your clipboard!